PDCD1 and melanoma: The m6A demethylase FTO enhances melanoma-intrinsic PD-1, CXC chemokine receptor type 4 (CXCR4) and SOX10 expression by erasing m6A marks, while simultaneously suppressing IFNγ response and anti-PD-1 efficacy 64.